Jubilant Pharmova has announced plans to secure ₹800 crore via its first bond issuance within the local market, featuring ₹400 crore as the base amount and an equal greenshoe option. The capital raised will be primarily allocated to the company’s capital expenditure and upcoming expansion efforts. Subscriptions are anticipated chiefly from mutual funds and asset managers, making this a significant moment in the company's bond market debut.